Literature DB >> 4186652

Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment.

U Larsson-Cohn, B Tengström, L Wide.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4186652     DOI： 10.1530/acta.0.0620242

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN： 0001-5598


× No keyword cloud information.
  8 in total

1.  Could family planning clients benefit from more nutrition counselling?

Authors:  C A Bonds; M G Powell; M A Yurkiw
Journal:  Can Fam Physician       Date:  1978-12       Impact factor: 3.275

Review 2.  [Metabolic studies under administration of oral contraceptives. A review].

Authors:  S Hauschildt
Journal:  Z Ernahrungswiss       Date:  1978-03

Review 3.  Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Effects of low-dose gestagen (lynestrenol 0.5 mg) and combination-type oral contraception (lynestrenol 1 mg and ethinyloestradiol 0.05 mg) on blood glucose and serum insulin levels after a glucose load.

Authors:  D Leis; P Bottermann; R Ermler; W Schlauch
Journal:  Arch Gynecol       Date:  1980

5.  Effects of oral contraceptives on carbohydrate metabolism.

Authors:  A Vermeulen; R Daneels; M Thiery
Journal:  Diabetologia       Date:  1970-10       Impact factor: 10.122

6.  Onset of diabetic ketoacidosis with symptoms of acute abdomen during oral mestranol treatment.

Authors:  E Mignani; E Maoli; G Castellana; S Marigo
Journal:  Acta Diabetol Lat       Date:  1974 Mar-Apr

7.  Diabetes and menstruation.

Authors: 
Journal:  Br Med J       Date:  1970-12-19

8.  Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone.

Authors:  D P Rose; P W Adams
Journal:  J Clin Pathol       Date:  1972-03       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.